Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2017

Mar 3, 2017

31949_dirs_2017-03-02_0cc15689-e444-4472-95a5-8ffc196ab751.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-02-28

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman, 10% Owner)
Reporting Person: WFD Ventures Fund II, L.P. (10% Owner, Director by Deputization)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-28 Ordinary Shares M 686836 $3.59 Acquired 19822874 Indirect
2017-02-28 Ordinary Shares F 324440 $7.60 Disposed 19498434 Indirect
2017-02-28 Ordinary Shares M 525618 $3.59 Acquired 20024052 Indirect
2017-02-28 Ordinary Shares F 248285 $7.60 Disposed 19775767 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-28 Warrants $3.59 M 686836 Disposed 2017-07-31 Ordinary Shares (686836) Indirect
2017-02-28 Warrants $3.59 M 525618 Disposed 2018-07-21 Ordinary Shares (525618) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 84699 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants $3.59 2017-07-31 Ordinary Shares (6498) 6498 Direct
Warrants $3.59 2018-07-21 Ordinary Shares (3879) 3879 Direct

Footnotes

F1: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

F2: Reflects 324,440 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 362,396 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P.

F3: Reflects 248,285 ordinary shares withheld by the issuer at the market price of $7.60 per share less an exercise price of $3.59 per share in connection with the cashless exercise of 277,333 warrants to purchase ordinary shares owned by WFD Ventures Fund II, L.P.

F4: The Amendment filed on Form 4/A on February 21, 2017 incorrectly reflected the total number of ordinary shares beneficially owned by WFD Ventures Fund II, L.P. WFD Ventures Fund II, L.P. beneficially owned 19,136,038 ordinary shares following the transactions reported by the aforementioned Form 4/A.

F5: The Amendment filed on Form 4/A on February 21, 2017 incorrectly reflected the total number of ordinary shares beneficially owned by William F. Doyle. William F. Doyle beneficially owned 84,699 ordinary shares following the transactions reported by the aforementioned Form 4/A.

F6: Currently exercisable as of the date hereof.